☆ 4.7 Review

How I approach the prevention and treatment of thrombotic complications in hospitalized patients

BLOOD (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Correction Critical Care Medicine

Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline (vol 162, pg e207, 2022)

James D. Douketis et al.

CHEST (2023)

添加到收藏夹

Article Engineering, Biomedical

2021 ELSO Adult and Pediatric Anticoagulation Guidelines

Ali B. McMichael et al.

Summary: These guidelines provide educational information for adult and pediatric anticoagulation in extracorporeal membrane oxygenation, aiming to support physicians and other health professionals in assessing and managing patients undergoing ECLS / ECMO. However, they are not consensus recommendations and do not guarantee successful outcomes. Adherence to guidelines should be coupled with clinical judgment and individual patient consultation.

ASAIO JOURNAL (2022)

添加到收藏夹

Article Anesthesiology

Regional anaesthesia in patients on antithrombotic drugs Joint ESAIC/ESRA guidelines

Sibylle Kietaibl et al.

Summary: This joint guideline provides evidence-based recommendations on reducing the risk of antithrombotic drug-induced hematoma formation in regional anesthesia and analgesia. The article highlights the importance of considering the timing of antiplatelet and anticoagulant drug administration, individual factors, and specific procedures in order to minimize bleeding risk.

EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2022)

添加到收藏夹

Letter Hematology

Current practices of standardized risk assessment for venous thromboembolism: Results from a global survey from the World Thrombosis Day steering committee

Aaron M. Wendelboe et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

添加到收藏夹

Article Hematology

Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with Edoxaban

Alexander P. Benz et al.

Summary: The study found that andexanet significantly decreased antifactor Xa activity and achieved good hemostasis in patients with acute major bleeding on edoxaban. The efficacy was similar to that observed in patients with bleeding on other anticoagulant drugs. The rate of thrombotic events in these patients was as expected.

THROMBOSIS AND HAEMOSTASIS (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjects

Jack Ansell et al.

Summary: The study evaluated the efficacy and safety of Ciraparantag in reversing anticoagulation induced by apixaban or rivaroxaban in healthy elderly adults. It was found that 60 mg of Ciraparantag achieved sustained reversal of apixaban, and 180 mg achieved sustained reversal of rivaroxaban. All doses of Ciraparantag were well tolerated by the subjects.

EUROPEAN HEART JOURNAL (2022)

添加到收藏夹

Correction Hematology

Addendum to the guideline on the peri-operative management of anti-coagulation and anti-platelet therapy (vol 175, pg 602, 2016)

Khalid Saja

BRITISH JOURNAL OF HAEMATOLOGY (2022)

添加到收藏夹

Article Clinical Neurology

2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association

Steven M. Greenberg et al.

STROKE (2022)

添加到收藏夹

Editorial Material Critical Care Medicine

How to manage anticoagulation during extracorporeal membrane oxygenation

Jerrold H. Levy et al.

INTENSIVE CARE MEDICINE (2022)

添加到收藏夹

Review Medicine, General & Internal

Evaluation of Direct Oral Anticoagulant Reversal Agents in Intracranial Hemorrhage A Systematic Review and Meta-analysis

Rahul Chaudhary et al.

Summary: The study evaluated the safety and outcomes of different DOAC reversal agents among patients with ICH, and found that the anticoagulation reversal rates and safety profiles of different reversal agents were similar. Additionally, there were no significant differences between 4F-PCC and AA in terms of anticoagulation reversal, mortality, or thromboembolic events.

JAMA NETWORK OPEN (2022)

添加到收藏夹

Article Critical Care Medicine

Perioperative Management of Antithrombotic Therapy An American College of Chest Physicians Clinical Practice Guideline

James D. Douketis et al.

Summary: The American College of Chest Physicians has issued a clinical practice guideline on the perioperative management of antithrombotic therapy for patients receiving long-term oral anticoagulant or antiplatelet therapy. The guideline provides recommendations for the management of patients receiving different types of anticoagulants or antiplatelet drugs and undergoing various types of surgery or procedures. The recommendations are based on the available evidence, but uncertainty remains for many of the perioperative management questions.

CHEST (2022)

添加到收藏夹

Article Hematology

Costs and Healthcare Resource Utilization Associated with Idarucizumab or Andexanet Alfa Oral Anticoagulant Reversal in Patients Hospitalized with Life-Threatening Bleeds

Alex C. Spyropoulos et al.

Summary: This study assessed the costs and healthcare resource utilization associated with the use of Idarucizumab and Andexanet Alfa for anticoagulant reversal therapy. It found that Idarucizumab was associated with significantly lower hospital and ICU costs, as well as a lower prevalence of intracranial hemorrhage compared to Andexanet Alfa.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

A single center 9-year experience in IVC filter retrieval-the importance of an IVC filter registry

Mark Sheehan et al.

Summary: This study evaluated the retrieval practices of inferior vena cava (IVC) filters at an academic hospital over a 9-year period. The results showed a high retrieval rate of 92.5% for eligible IVC filters, highlighting the importance of maintaining a prospective IVC filter registry.

CVIR ENDOVASCULAR (2022)

添加到收藏夹

Review Surgery

Systematic review on the benefit of graduated compression stockings in the prevention of venous thromboembolism in low-risk surgical patients

M. Machin et al.

Summary: This systematic review aimed to assess the performance of graduated compression stockings (GCS) in preventing hospital-acquired thrombosis in low-risk surgical patients, but found no evidence to support the use of GCS in this population.

PHLEBOLOGY (2021)

添加到收藏夹

Article Hematology

Ciraparantag, an anticoagulant reversal drug: mechanism of action, pharmacokinetics, and reversal of anticoagulants

Jack Ansell et al.

Summary: Ciraparantag is a small molecule designed to reverse the effects of anticoagulants, showing rapid onset and short half-life. It has the potential to reduce blood loss in animal models and serve as a DOAC reversal agent.

BLOOD (2021)

添加到收藏夹

Article Anesthesiology

The Society for Obstetric Anesthesia and Perinatology Interdisciplinary Consensus Statement on Neuraxial Procedures in Obstetric Patients With Thrombocytopenia

Melissa E. Bauer et al.

Summary: A significant proportion of obstetric patients may have thrombocytopenia, leading anesthesiologists to carefully assess the risks and benefits of neuraxial procedures. Shared decision-making with patients based on individual risks and preferences is crucial in determining whether to proceed with such procedures.

ANESTHESIA AND ANALGESIA (2021)

添加到收藏夹

Review Critical Care Medicine

Andexanet Alfa or Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Acute Major Bleeding: A Systematic Review and Meta-Analysis

Charlie J. Nederpelt et al.

Summary: This study combines evidence on andexanet alfa and prothrombin complex concentrates for factor Xa inhibitor-associated bleeding, finding no significant differences in clinical effectiveness between the two reversal agents, neither showing clear superiority nor increased adverse events.

CRITICAL CARE MEDICINE (2021)

添加到收藏夹

Article Critical Care Medicine

A Comparison of Thrombosis and Hemorrhage Rates in Patients With Severe Respiratory Failure Due to Coronavirus Disease 2019 and Influenza Requiring Extracorporeal Membrane Oxygenation

Andrew J. Doyle et al.

Summary: This study revealed that patients with coronavirus disease 2019 receiving extracorporeal membrane oxygenation had higher rates of venous thromboembolism and hemorrhage compared to patients with influenza.

CRITICAL CARE MEDICINE (2021)

添加到收藏夹

Article Critical Care Medicine

Antithrombotic Therapy for VTE Disease Second Update of the CHEST Guideline and Expert Panel Report

Scott M. Stevens et al.

Summary: This is the 2nd update to the 9th edition of guidelines, providing recommendations on 17 PICO questions, with four new questions addressed. Strong and weak recommendations were generated based on high-, moderate-, and low-certainty evidence, resulting in 29 guidance statements, 13 of which are strong recommendations. New evidence has emerged since 2016, improving the standard of care for VTE patients, but substantial uncertainty remains regarding certain important management questions.

CHEST (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants

Antonio Gomez-Outes et al.

Summary: This study investigated the clinical outcomes associated with the use of different reversal agents for severe DOAC-related bleeding, finding a high rate of effective hemostasis but a significant association between failure to achieve effective hemostasis and mortality risk. Thromboembolism rates were particularly high with andexanet.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

添加到收藏夹

Article Anesthesiology

Anticoagulation Management and Antithrombin Supplementation Practice during Veno-venous Extracorporeal Membrane Oxygenation A Worldwide Survey

Alessandro Protti et al.

ANESTHESIOLOGY (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage

Jennifer A. Frontera et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)

添加到收藏夹

Editorial Material Surgery

Another nail in the coffin of vena cava filters

A. J. Doyle et al.

BRITISH JOURNAL OF SURGERY (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants A Report of the American College of Cardiology Solution Set Oversight Committee

Gordon F. Tomaselli et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

添加到收藏夹

Article Hematology

Management and outcomes of newborns at risk for inherited antithrombin deficiency

Roza Chaireti et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Article Critical Care Medicine

A Randomized Controlled Trial of Antithrombin Supplementation During Extracorporeal Membrane Oxygenation

Mauro Panigada et al.

CRITICAL CARE MEDICINE (2020)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Society of Interventional Radiology Clinical Practice Guideline for Inferior Vena Cava Filters in the Treatment of Patients with Venous Thromboembolic Disease

John A. Kaufman et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study

Alfonso J. Tafur et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

添加到收藏夹

Article Education, Scientific Disciplines

Inferior vena cava filters: a framework for evidence-based use

Amar H. Kelkar et al.

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Perioperative antithrombotic management of patients who receive direct oral anticoagulants during gastroenterological surgery

Takahisa Fujikawa et al.

ANNALS OF GASTROENTEROLOGICAL SURGERY (2020)

添加到收藏夹

Article Hematology

A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers

Genmin Lu et al.

BLOOD ADVANCES (2020)

添加到收藏夹

Article Medicine, General & Internal

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

S. J. Connolly et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Hematology

Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient-specific thromboembolic risk

Alex C. Spyropoulos et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)

添加到收藏夹

Editorial Material Medicine, General & Internal

Preventing hospital associated venous thromboembolism

Beverley J. Hunt

BMJ-BRITISH MEDICAL JOURNAL (2019)

添加到收藏夹

Article Medicine, General & Internal

Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant

James D. Douketis et al.

JAMA INTERNAL MEDICINE (2019)

添加到收藏夹

Article Hematology

The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications

Mirjana Kovac et al.

THROMBOSIS RESEARCH (2019)

添加到收藏夹

Review Hematology

Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum

Adam Cuker et al.

AMERICAN JOURNAL OF HEMATOLOGY (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Andexanet Alfa: First Global Approval

Young-A Heo

DRUGS (2018)

添加到收藏夹

Review Hematology

International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

Robert C. Gosselin et al.

THROMBOSIS AND HAEMOSTASIS (2018)

添加到收藏夹

Review Anesthesiology

International consensus statement on the peri-operative management of direct oral anticoagulants in cardiac surgery

G. Erdoes et al.

ANAESTHESIA (2018)

添加到收藏夹

Article Hematology

American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy

Shannon M. Bates et al.

BLOOD ADVANCES (2018)

添加到收藏夹

Article Hematology

Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation

Yvonne M. C. Henskens et al.

THROMBOSIS JOURNAL (2018)

添加到收藏夹

Article Medicine, General & Internal

Idarucizumab for Dabigatran Reversal - Full Cohort Analysis

Charles V. Pollack et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Review Medicine, General & Internal

Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis

Jose A. Lopez-Lopez et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

添加到收藏夹

Review Medicine, General & Internal

Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis

Jose A. Lopez-Lopez et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

添加到收藏夹

Article Critical Care Medicine

Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants

Bethany T. Samuelson et al.

CHEST (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Laboratory measurement of the non-vitamin K antagonist oral anticoagulants: selecting the optimal assay based on drug, assay availability, and clinical indication

Adam Cuker

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)

添加到收藏夹

Article Medicine, General & Internal

Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial

Robert P. Giugliano et al.

AMERICAN JOURNAL OF MEDICINE (2016)

添加到收藏夹

Article Hematology

When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH

J. H. Levy et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)

添加到收藏夹

Article Medicine, General & Internal

Effect of a Retrievable Inferior Vena Cava Filter Plus Anticoagulation vs Anticoagulation Alone on Risk of Recurrent Pulmonary Embolism A Randomized Clinical Trial

Patrick Mismetti et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

添加到收藏夹

Review Nutrition & Dietetics

New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs)

Rick H. van Gorp et al.

NUTRIENTS (2015)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

Claes Held et al.

EUROPEAN HEART JOURNAL (2015)

添加到收藏夹

Article Hematology

Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials

N. van Es et al.

BLOOD (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Laboratory Measurement of the Anticoagulant Activity of the Non-Vitamin K Oral Anticoagulants

Adam Cuker et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the US Adult Population

Susan Colilla et al.

AMERICAN JOURNAL OF CARDIOLOGY (2013)

添加到收藏夹

Article Surgery

Weight-based enoxaparin dosing for venous thromboembolism prophylaxis in the obese trauma patient

Annika Bickford et al.

AMERICAN JOURNAL OF SURGERY (2013)

添加到收藏夹

Article Hematology

How I treat heterozygous hereditary antithrombin deficiency in pregnancy

Kate Bramham et al.

THROMBOSIS AND HAEMOSTASIS (2013)

添加到收藏夹

Article Health Care Sciences & Services

The global burden of unsafe medical care: analytic modelling of observational studies

Ashish K. Jha et al.

BMJ QUALITY & SAFETY (2013)

添加到收藏夹

Article Education, Scientific Disciplines

Pros and cons of new oral anticoagulants

Kenneth A. Bauer

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2013)

添加到收藏夹

Article Hematology

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients

S. Schulman et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)

添加到收藏夹

Article Hematology

Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations

Andreas Tiede et al.

THROMBOSIS AND HAEMOSTASIS (2008)

添加到收藏夹

Article Hematology

Guidelines on use of vena cava filters

T. P. Baglin et al.

BRITISH JOURNAL OF HAEMATOLOGY (2006)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.